Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Regenerative MedicineCell Therapy

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1564053

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1564053

Canine Stem Cell Therapy

PUBLISHED:
PAGES: 197 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 14850

Add to Cart

Description

Table of Contents

Global Canine Stem Cell Therapy Market to Reach US$253.8 Million by 2030

The global market for Canine Stem Cell Therapy estimated at US$200.1 Million in the year 2023, is expected to reach US$253.8 Million by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Allogeneic Stem Cells, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$174.8 Million by the end of the analysis period. Growth in the Autologous Stem Cells segment is estimated at 2.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$52.9 Million While China is Forecast to Grow at 3.3% CAGR

The Canine Stem Cell Therapy market in the U.S. is estimated at US$52.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$40.6 Million by the year 2030 trailing a CAGR of 3.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Canine Stem Cell Therapy Market - Key Trends and Drivers Summarized

Why Is Canine Stem Cell Therapy Gaining Popularity in Veterinary Medicine?

Canine stem cell therapy has rapidly gained traction as a revolutionary treatment in veterinary medicine, offering hope for conditions that were once difficult to manage in dogs, particularly degenerative diseases, injuries, and immune disorders. Stem cells, especially those derived from a dog's own fat tissue (adipose-derived stem cells), have the unique ability to regenerate damaged tissues, reduce inflammation, and promote overall healing. This therapy is most commonly used to treat musculoskeletal conditions like osteoarthritis, hip dysplasia, and ligament injuries—ailments that cause significant pain and limited mobility in dogs, particularly as they age. Traditional treatments for these conditions, such as non-steroidal anti-inflammatory drugs (NSAIDs), physical therapy, or even surgical interventions, can offer temporary relief but often come with side effects or the risk of complications. Stem cell therapy, by contrast, offers a less invasive solution with the potential for longer-lasting results. It works by harnessing the body’s natural healing processes, making it a more holistic approach to treating conditions that affect a dog’s mobility and quality of life. As more veterinarians and pet owners recognize its benefits, the demand for canine stem cell therapy has grown, reflecting a broader shift toward advanced regenerative therapies in animal care.

How Is Technology Advancing Canine Stem Cell Therapy?

The success and expanding reach of canine stem cell therapy are closely tied to rapid advancements in biotechnology and regenerative medicine. Over the past decade, significant progress has been made in how stem cells are processed and administered, improving the safety, efficacy, and convenience of these treatments for both veterinarians and pet owners. One major development is the refinement of methods for harvesting and processing adipose-derived stem cells, where stem cells can now be extracted, purified, and expanded in specialized laboratories with greater speed and precision. This allows for quicker treatment cycles and improved outcomes, as the quality and viability of the stem cells have a direct impact on their therapeutic potential. Additionally, the use of allogeneic stem cells, which are derived from donor animals, is an emerging trend, particularly for cases where it may not be feasible to collect stem cells from the patient. This approach broadens the availability of treatments, offering a solution even for dogs with underlying conditions that complicate autologous stem cell collection. Another significant advancement is in cryopreservation techniques, which allow harvested stem cells to be stored long-term and reused in future treatments without requiring repeated surgeries. These technological innovations, combined with the use of imaging technologies like MRI and ultrasound for precise targeting of stem cell injections, have made stem cell therapy not only more accessible but also more effective at addressing complex and chronic conditions.

What Trends and Challenges Are Shaping the Canine Stem Cell Therapy Market?

Several key trends are shaping the rapid growth and evolution of the canine stem cell therapy market, driven largely by the increasing demand for non-invasive, regenerative treatments for pets. As pet owners become more informed about advanced veterinary care options, there is a growing preference for therapies that can deliver better outcomes with fewer side effects compared to conventional treatments. This trend aligns with a broader movement in the pet care industry toward holistic and integrative treatments, where the focus is on promoting overall wellness and addressing the root causes of conditions rather than just managing symptoms. Moreover, the expanding research and clinical evidence supporting the efficacy of stem cell therapy in treating degenerative joint diseases, such as osteoarthritis, has bolstered its credibility among veterinarians, further encouraging its adoption. However, despite these positive trends, the market faces several challenges. One of the main hurdles is the cost of treatment, which remains high for many pet owners, potentially limiting access to this advanced therapy. There is also a need for more regulatory oversight to ensure the consistency and quality of stem cell products, as variations in how stem cells are processed can impact their safety and effectiveness. Moreover, while stem cell therapy has shown promise in treating a variety of conditions, long-term studies are still needed to fully understand its potential and limitations. Despite these challenges, the increasing number of success stories and ongoing innovations in the field suggest that the future of canine stem cell therapy is bright.

What Factors Are Propelling Growth in the Canine Stem Cell Therapy Market?

The growth in the canine stem cell therapy market is driven by several factors, including advancements in veterinary science, increased awareness of regenerative medicine, and the rising demand for minimally invasive treatment options for aging and injured dogs. A key driver of this growth is the increasing prevalence of chronic conditions such as osteoarthritis, hip dysplasia, and ligament injuries in dogs, particularly as pet lifespans increase due to improved healthcare. As dogs live longer, the need for treatments that can enhance their quality of life without relying on invasive surgery or long-term medications becomes more critical. Stem cell therapy provides a viable solution, offering regenerative benefits that can significantly improve mobility and reduce pain. Additionally, advancements in the processing and storage of stem cells, including cryopreservation and the use of allogeneic stem cells, have made the therapy more accessible to a wider range of veterinary practices, further driving its adoption. Consumer behavior also plays a significant role, as pet owners become more educated about the potential benefits of stem cell therapy and seek alternatives to traditional treatments for their pets. The increasing availability of stem cell therapy at veterinary clinics, coupled with partnerships between biotech companies and veterinary practices, is helping to commercialize the therapy and make it more mainstream. Furthermore, the rising interest in personalized veterinary care, where treatments are tailored to the specific needs of individual pets, continues to propel the market, as stem cell therapy offers a highly customizable approach to treating a wide range of conditions. With ongoing advancements in biotechnology and growing consumer interest, the canine stem cell therapy market is poised for sustained growth in the coming years.

Select Competitors (Total 47 Featured) -

  • Animal Cell Therapies, Inc
  • Aratana Therapeutics, Inc.
  • Cell Therapy Sciences
  • Magellan Stem Cells
  • MediVet Biologics, LLC
  • Okyanos
  • Regeneus Ltd.
  • Stem Cell Vet
  • Vetbiologics
  • VetMatrix
Show more
Product Code: MCP10870

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Canine Stem Cell Therapy - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Canine Osteoarthritis Throws the Spotlight on Stem Cell Therapy as a Key Treatment Option
    • Here's How Advancements in Regenerative Medicine Drive Adoption of Canine Stem Cell Therapy
    • Growing Demand for Minimally Invasive Treatments Spurs Growth in Stem Cell Therapy for Pets
    • Increasing Pet Ownership and Spending on Pet Healthcare Expands Addressable Market Opportunity for Stem Cell Therapies
    • Here's the Story: Improved Stem Cell Isolation Techniques Propel Growth in Treatment Efficacy
    • Advances in Cryopreservation Technologies Generate New Opportunities for Repeat Stem Cell Treatments
    • Growing Interest in Alternative Therapies for Pain Management Propels Adoption of Stem Cell Treatments
    • Research on Stem Cell Applications for Immune and Neurological Disorders Expands Treatment Horizons
    • Increased Availability of Stem Cell Therapies in Specialty Veterinary Clinics Drives Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Canine Stem Cell Therapy Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Canine Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Canine Stem Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Allogeneic Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Autologous Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Autologous Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Autologous Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Veterinary Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Veterinary Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Veterinary Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Veterinary Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Veterinary Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Veterinary Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Veterinary Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Veterinary Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Veterinary Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • JAPAN
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • CHINA
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • EUROPE
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Canine Stem Cell Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Canine Stem Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • FRANCE
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • GERMANY
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: Rest of Europe 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: Asia-Pacific 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of World 16-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2014, 2024 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!